Journal
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Volume 11, Issue 2, Pages 147-157Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERI.12.164
Keywords
Acinetobacter baumannii; antimicrobial stewardship; carbapenem resistance; Enterobacteriaceae; epidemiology; Escherichia coli; Gram negative; infection prevention; Klebsiella pneumoniae; Pseudomonas aeruginosa; resource-limited settings
Funding
- National Research University Project of the Thailand Office of Higher Education Commission
- Infectious Diseases and Infection Control Research Unit
Ask authors/readers for more resources
Emergences of carbapenem-resistant Gram-negative bacteria (CRGNB) have heightened global awareness of the prioritization of infection prevention and control (IPC) interventions to minimize infections attributed to these bacteria. Effective new antibiotic drugs for CRGNB are estimated to be at least 5 years off completion of trials and approval for use. Hence, effective IPC strategies remain at the core of clinical care and research for patients with CRGNB infection. The authors summarize current evidence and viewpoints for IPC strategies as related to the emergence, transmission and prevention of CRGNB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
